Company/Products Feed and nutrition Research and innovation Ceva Phylaxia inaugurates state of the art vaccine plant to support “Innovation with Impact“ growth plan 7,8 billion forint (€ 25m) investment will significantly increase production at its Budapest Campus. 18 July 2017 2 minute read Europe Sponsored Article CEVA Our Partners Lallemand Lanxess Hamlet Protein Thermo Fisher Scientific Axcentive More News View all Lean hogs end day mixed - CME Market Trends Markets and economics 25 April 2024 2 minute read Canada's worries about Bunge-Viterra deal may force asset sales Market Trends Feed markets 25 April 2024 3 minute read Competition Bureau worried about reduced competition for farmers EU Parliament approves weakened green rules for farmers Policy and regulation 25 April 2024 2 minute read The proposal needs final approval from EU countries Sponsored Article CEVA Our Partners Lallemand Lanxess Hamlet Protein Thermo Fisher Scientific Axcentive